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Abstract
The Determining Factors of the Self-assembly of Collagen Mimetic Peptide
by
Fangfang Chen
Adviser: Dr. Yujia Xua

We recently reported that a designed triple helix Col108 self-associates to form collagen-like minifibrils having a d-periodicity of 35 nm. Recombinant protein Col108 consists of 378-residue triple
helix domain organized into three repeating sequence units, and a C-terminal foldon domain. The
35 nm d-period of Col108 mini-fibrils is consistent with the one unit staggered arrangement of the
associating helices. To further investigate if the sequence periodicity is crucial for collagen
mimetic peptide fibril formation, we studied the self-assembly of four other designed triple helical
peptides. Peptide 2U108 has two repeating sequence units; peptide Col877 consists of three
repeating units but the amino acid sequence of each unit is very different from that of Col108;
peptide 1U108 has only one sequence unit and peptide. Col108r has the same amino acid
composition of that of Col108 but lacks the sequence periodicity. Both 2U108 and Col877 formed
mini-fibrils having the same periodicity of 35 nm as that observed in Col108 under electron
microscopy, but no fibril-like assemblies were observed for either 1U108 or Col108r. Since both
2U108 and Col877 have tandem repeats of sequence units while 1U108 and Col108r do not, these
findings support the essential roles of the long-range repeating sequence units on the self-assembly
of collagen-like, staggered fibrils and suggest a design-rule for the self-assembly of triple helices
into collagen-like mini-fibrils.
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Chapter 1. Introduction
1.1 Collagen protein family
Collagen is the major structural protein in the extracellular matrix and the most abundant
protein in animals. Collagen provides structural integrity and malleability to all internal organ (1).
Most collagens are able to form supramolecular aggregates.
So far, 29 distinct types of collagens have been identified and divided into several
subgroups based on their supramolecular structure and function (2,3). The subgroups of collagen
include fibril forming collagen, fibril associated collagen containing interrupted triple helices
(FACITs), collagen from beaded filament, collagen in basement membrane, and anchoring fibril
and network forming and transmembrane collagens. The supramolecular structures of collagen
subfamily are shown in Figure 1-1. Fibril forming collagens comprise major collagen type I, II,
III, and minor type V, XI, XXIV and XXVII and compose 90% of proteins in extracellular matrix.
FACITs and related collagens including collagens type IX, XII, XIV, XVI, XIX, XX, XXI, XXII
and XXVI are relatively short proteins and do not form fibrils themselves, but are associated with
the surface of fibrils of collagen fibrils (4). Membrane collagen and collagen-like membrane
proteins including collagen XIII, XVII, XXIII and XXV, contain a transmembrane domain and do
not form supramolecular structure. Multiplexins (multiple triple helix domains and interruptions)
including types XV and XVIII have a triple helical domain with some interruptions. Collagen XV
can form oligomeric assemblies and is found to bridge neighboring collagen fibrils near basement
membranes (5). Anchoring fibrils and beaded-filament-forming collagens, known as microfibrillar
collagens including VI, VII, XXVI and XXVIII, are widely spread in the body. Network-forming
collagens including type IV, VI, VIII and X collagen are found in extracellular matrix which
1

supports epithelial cells, muscle fibers, and peripheral nerves (3).

Figure 1-1 Schematics of collagen family. (taken from van der Rest M et al (6)).
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1.2 Fibrillar collagens
The fibril-forming collagens including collagen type I, II, III, V and XI are characterized
by their ability to self-assemble into fibrils (3). The supramolecular structure of collagen fibrils is
defined by a characteristic 67nm periodicity: a banding pattern characterized using electron
microscopy. The collagen molecules are composed of a triple helix domain that contain around
1000 residues in Gly-X-Y repeating sequence flanked by short non-helical telopeptide at both ends.
The individual triple helix in type I collagen is about 1.5 nm in diameter and 300 nm in length (6)
Type I collagen is most abundant protein and the major protein in bone, tendons, skin,
ligaments, cornea, and many interstitial connective tissues except cartilage (3). The type I collagen
triple helix is composed of two a1(I) chains and one a2(I) chain. Minor amounts of type I collagen
are homotrimer composed of three a1(I) chains in embryonic tissues (7). The molecular
mechanism of forming heterotrimer vs homotrimer type I collagen remains unknown.
Homotrimeric type I collagen is found to be resistant to all mammalian collagenases (8). The
homotrimers can still assemble into fibrils with the same periodicity as that of heterotrimers. Type
I Collagen molecules self-assemble to form striated fibrils with a periodicity of 67 nm (5). In the
fibril, collagen molecules are arranged in staggered arrays. The stagger is equal to the D period
(67 nm). The length of single collagen molecule is 4.4 D. Thus, there is a 0.6 D gap between the
ends of neighboring molecules. The gap-overlap structure gives rise to D-periodic banding pattern
of collagen fibrils. The D-periodic banding plays an important role in high tensile strength and
bone mineralization (9,10).

The mutations in genes coding for type I collagen interfere with the folding of triple helix,
assembly of collagen molecules and interaction with other molecules in extracellular matrix. The
3

common type I collagen-related diseases are osteogenesis imperfecta (OI) and Ehlers-Danlos
syndrome (EDS). The characteristic features of OI are brittle bones, blue sclerae, abnormal teeth,
thin skin, weak tendons and hearing loss (11). Most of the mutations are the substitution of glycine
in Gly-X-Y pattern with other amino acid. Other mutations contain deletions, insertion and RNA
splicing defects (11). EDS is characterized by hypermobility and skin abnormality (12). These
disorders are caused by a failure to cleave N-termini propeptide due to a mutation at N-terminal
cleavage site. Without cleavage of N-termini propeptide, collagen molecules are not able to selfassemble to fibrils. Some diseases related to homotrimeric type I collagen are cancer, osteoarthritis,
osteoporosis and fibrosis (7).
Type II collagen is the major constituent of cartilage and a homotrimer formed by three
a1(II) chains. Type II collagen covalently interacts with type IX and V/XI collagens to form
heterotypic fibrils in the cartilage matrix (13). Type V/XI collagen is a heterotrimeric molecule
composed of a1(XI), a2(XI), a3(XI) chains. Type III collagen mostly exists in soft connective
tissues such as embryonic skin, lung and blood vessels. Type III collagen is a homotrimer of three
a1(III) chains. Type III collagen assembles into fibrils with type I collagen in some tissues.

1.3 Hierarchical structure of collagen
The triple helix conformation of collagen is unique. All of the collagen molecules are made
up with three polypeptide chains. The three α chains are supercoiled in a right hand manner in the
triple helix and each is in a polyproline II like conformation. Each polypeptide chain contains the
repeating Gly-X-Y pattern in which glycine residue occupies at every third position. Glycine is
the smallest amino acid residue and the only residue that can fit tightly in the center of triple helix.
X and Y can be any of the 21 amino acid residues but are frequently proline (at X position) and
4

4R-hydroxyproline (Hyp, at Y position). If glycine is replaced by other residue, the triple helix
motif is interrupted. The triple helical structure was proposed by Ramachandran and Kartha (14).

These three polypeptide chains of the triple helix are stabilized by interchain hydrogen
bond. N-H of glycine interacts in one chain with C=O of the residue in the X position of
neighboring chain to form hydrogen bond (Figure 1-2). Hydrogen bonds are perpendicular to the
helix axis. Not all backbone peptides of the repeating tripeptides are involved in hydrogen bonds
in triple helix (15). Each repeating tripeptide form one hydrogen bond. If X or Y residues are not
Pro (proline) or Hyp, there are second hydrogen bonds between N-H of the X position residue and
the C=O of the Gly residue(16). Water molecules are involved in these hydrogen bonds. Watermediated hydrogen bonds stabilize the collagen triple helices.

Figure 1-2 The pattern of hydrogen bonds in triple helix (taken from reference (18)).

The hierarchical structure of collagen starts with a long polypeptide chain – the alpha chain,
consisting of the triple helix domain, and the N- C propeptides. The folding in ER generates
5

trimeric procollagen. The N- and C- globular domains are removed in the extracellular space to
generate tropocollagen. Tropocollagen molecules self-associate to form fibrils with D-periodicity
in appropriate conditions. Collagen fibrils have a diameter of 100 - 500 nm and their length is
around micrometer. Multiple collagen fibrils aggregate spontaneously to form collagen fibers
mediated by cross-linking macromolecules such as proteoglycans and FACIT collagens (9).The
size and shape of collagen fibers vary depending on tissues and organs. The diameter of collagen
fibers is 1 to 100 µm thick. The length of fibers is around milimeter (17).
The structure of collagen fibril is characterized by 67 nm axial periodicity, also called D
periodicity shown in Figure 1-3 (18). The uninterrupted triple helix in fibril-forming collagen
molecules is about 300 nm length and 1.5 nm in diameter (19). In the linear conformation of the
triple helix having a uniform helix rise of 0.8 - 0.9 nm per Gly-X-Y triplet, a 234 residue segment
correlates to a ~ 67 nm segment, Thus, each Collagen triple helix encompasses 4.4 D periods, each
D-period is about 67nm and includes 234 residues. The D-periodicity of collagen fibrils is
composed of overlap and gap regions in the staggered arrangement. Under electron microscope,
the overlap region (light band) is ~ 27 nm and gap region (dark band) is ~ 40 nm in negatively
stained fibrils (19). Studies using X-ray fiber diffraction have linked 67 nm D-period of collagen
fibrils to 234 residues staggered pattern of triple helices (20). It is postulated that in the 234
residues staggered arrangement, hydrophobic and electrostatic interaction is maximized (21).
However, it remains unclear what properties of the triple helix make this staggered arrangement a
unique conformation during fibril formation. It is also not clear what specific amino acid residues
are involved in these interactions and if the specific placement of these residues along the triple
helix has any connection with the 234-residues staggered arrangement.

6

Figure 1-3 Axial structure of D-periodic collagen fibrils (taken from reference (30)). (a) Schematic
representation of the axial arrangement of triple helical collagen molecules in a fibril. (b) Negatively stained
fibril shown under electron microscopy.

1.4 Fibril-forming collagen biosynthesis
Most collagens assemble into supramolecular architectures by self-assembly or by
interacting with other collagen molecules. The specific pathways of Fibril-forming collagen
biosynthesis are discussed below (Figure 1-4).

1.4.1 Intracellular step
All individual collagen chains are synthesized on the ribosome and translocated into the
lumen of rough endoplasmic reticulum (ER). A series of post-translational modifications happen
including hydroxylation of proline at Y-position and selected lysine residues (22). In fibrillar
collagens, nearly all Pro on Y position are hydroxylated. Some hydroxylysine residues are further
glycosylated to form galactosyl-hydroxylysine and glucosyl-galactosyl hydroxylysine.
Hydroxylysine also plays crucial roles in stabilizing triple helix by forming cross-links between
collagen molecules in fibrils.
7

Following the hydroxylation of proline and lysine and glycosylation of hydroxylysine,
individual collagen chains associate together to form the triple helix, which is often referred to as
the procollagen. In fibril-forming collagens, C terminus propeptide plays an important role in
selecting and trimerizing three appropriate α chains to form triple helix but prevent fibril formation
(23). Collagen molecules are nucleated and elongated in C- to N- direction after initiation by C
propeptide. During the trimerization, intramolecular and intermolecular disulfide bonds are formed
by protein disulfide isomerase (PDI) (24). Type I collagen does not have disulfide bonds. All
fibrillar collagens are synthesized to soluble procollagen with N- and C- terminal propeptide
domains. Once post-translational modifications and folding are completed, procollagen molecules
are transported to the Golgi apparatus. In Golgi, procollagen molecules form triple helices. The
triple helices are secreted into extracellular parts.

1.4.2 Extracellular step

After procollagen molecules are secreted into extracellular space and N- and C-propeptides
are cleaved by procollagen N-proteinase and C-proteinase respectively, collagen molecules
aggregate to form fibrils. In the process of fibrillogenesis, specific lysines and hydroxylysines in
the N- and C- telopeptides are oxidatively deaminated by lysyl oxidase to allysine and
hydroxyallysine respectively (25). Aldehyde groups of allysine and hydroxyallysine react with
amine groups of lysine and hydroxylysine in the telopeptides to form intra- and inter-molecular
cross-links. The role of cross-links is critical in stabilizing fibrils and providing tensile strength
and mechanical stability to connective tissues (26,27).

8

Figure 1-4 The main procedures of collagen triple helices self-assembled into collagen fibrils (taken from
reference (19)). Three α chains are selected and trimerized by carboxyl propeptides to form triple helix. The
N- and C-propeptides of triple helices are cleaved by proteinases in the extracellular matrix. The triple
helices are staggered to form cross-striated fibrils.

1.5 Collagen mimetic models
Collagen is very useful as a biomaterial for medical and nanotechnological application due
to molecular properties such as low antigenicity, biodegradability and high compatibility (28).
However, collagen isolated from natural sources and by expression is difficult to modify, lack of
purity, affected by post-translational modifications and can induce pathogenic and immunological
side effects (29). Studies utilize “bottom-up” approach for molecular design focused on generating
self-assembly from peptides. The different types of fibrils are shown in Figure 1-5. Collagen
9

mimetic peptides are designed to mimic multiple levels of collagen’s structural hierarchy and study
the details of the molecular mechanism of fibril formation. The peptides may also provide a tool
to study interactions with other proteins and cells that require higher ordered structure.

Figure 1-5 Self-assemblies of triple helical peptides. (A) Self-assembled structure of (Pro-Hyp-Gly)10 is from
Dr. Brodsky’s lab. (taken from Kar et al. (26)). (B) CPB:CPC samples that assemble into fibrils at mixing
ratio 6:8 are from Dr. Nanda’s lab (taken from Xu et al. (34)). (C) The well defined periodic microfibrils are
from Dr. Chaikof’s lab. The gap region is around 6.7 nm. The overlap region is around 11.2 nm. (taken from
Przybyla et al. (4)) (D) The synthetic peptide that assembles into nanofibrils is from Dr. Hartgerink’s lab.
The fibril is much thinner than natural collagen fibrils. (taken from O'Leary et al. (38))

Raines et al. have used triple helical propensity to study the assembly of synthetic collagen
peptides with sticky ends (30). They designed and constructed two synthetic collagen fragments
with overhanging (Pro-Yaa-Gly)5. Collagen fragments self-assemble to thin and long fibrils via
10

intermolecular triple helix formation. Some fibrils are longer than natural collagen triple helices.
Also, they found that the length of fibrils is modulated by thermal stability, amino acid composition,
temperature and solvent. The fibrils formed from synthetic collagen peptide through sticky ends
is different from the staggered arrangement of natural collagen molecules. These collagen-like
fibrils formed through the intermolecular assembly of the overhanging (Pro-Yaa-Gly)5 segments.
Natural collagen molecules assemble into long fibrils with D periodicity through 234 residues
staggered arrangement.
Brodsky et al. have reported a triple helix peptide (Pro-Hyp-Gly)10 that self-associates to
disordered aggregates with branched, filamentous structures under defined temperature, pH and
concentration (18). In this model, intermediate loosened state of the triple helix and water
molecules associated with triple helix are thought to be crucial factors for self-association. The Tm
of the peptide (Pro-Hyp-Gly)10 is ~ 60°C. The hydrated triple helix transfers to loosened state with
temperature higher than 35°C. And then loosened triple helix interacting with water starts to selfassociate to supermolecular form or a denatured monomer state. There are a number of similarities
between fibril formation process of this peptide and natural collagen discussed below. Both
Collagen fibril formation and the self-association of this peptide are optimal in neutral pH and do
not occur in low pH. With increasing temperature, collagen fibril formation and the association of
this peptide are faster (31). Similar to collagen fibril formation, the assembly of the peptide is a
reversible process. However, this peptide forms a disorganized structure in contrast to higher order
structure of natural collagen fibrils.
Yoshizumi et al. reported a recombinant triple helix consisting of two tandem collagen
domains, the peptide CL-CL, formed fibrillar structures at neutral pH (32,33). The fibril structure
was characterized as bundled in-register arrays of the triple helices, but has no D-period like axial
11

structures. They attributed the lack of D-periodicity to the insufficient size of the CL-CL triple
helix.
Nanda et al. presented that synthetic peptides (CPB and CPC) through non-covalent
electrostatic interaction assembled into fibrils and hydrogel (34,35). The amino acid sequence of
CPB is PEGEOGROGROGPRGPRGPRGROGROGPRG. The amino acid sequence of CPC is
PRGROGROGROGPRGEOGPEGPEGEOGEOG. The morphology of high order assembly
depends on concentration and mixing the stoichiometry of CPB and CPC (34). They also indicate
that triple helical intermediate is a prerequisite for the formation of high order structure. Individual
synthetic peptides are associating perpendicular to the fiber axis. No periodic banding pattern is
found in these fibrils. Recently Nanda’s lab found that a new synthetic peptide H4 self-assembles
into discs driven by hydrophobic interactions between the central (LIG)2 domains of triple-helices
(36). The thickness of discs are ~ 10 nm that is equal to the length of H4 triple helix. The discs coassemble with natural collagen by hydrophobic interaction. This peptide scaffold contributes to
study the molecular mechanism of collagen fibril formation.

Chaikof and co-workers designed a fibril-forming collagen-like peptide that includes 36
amino acid residues with the sequence (Pro-Arg-Gly)4(Pro-Hyp-Gly)4(Glu-Hyp-Gly)4 (37). This
collagen-like peptide self-assembles into microfibrils with 18 nm periodicity through electrostatic
interaction. The fibrillogenesis of collagen-like peptide is through axially staggered assembly
between oppositely charged residues Arg and Glu of triple helicies. However, the temperature for
fibrils formation is higher than melting temperature of triple helices. It indicates that triple helices
are unfolded during self-assembly of collagen-like peptide. The predicted model of collagen-like
peptide fibrillogenesis assumes the microfibril is formed assembly between oppositely charged Nand C-terminal ends of triple helicies.
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Hartgerink et al. constructed a new synthetic collagen mimetic peptide based on the
analysis of different electrostatic interactions between charged amino acids (38). The difference
between this peptide and the work of Chaikof and Conticello is that Hartgerink’s group replaced
Arg with Lys and Glu with with Asp. The charged pairs of Lys and Asp form stronger salt-bridge
hydrogen bonds than charged pairs of Arg and Glu. The sequence of this designed peptide is (ProLys-Gly)4(Pro-Hyp-Gly)4(Asp-Hyp-Gly)4. The results show that collagen mimetic peptides
assembled into nanofibers by triple helical nucleation. Axial charged pairs between (PKG)4 and
(DOG)4 facilitate to form sticky ended triple helices. The Lys and Asp side chains that do not
participate in intrahelical salt bridges promote to form triple helix bundles through interhelix
interactions.

1.6 Collagen mimetic mini-fibrils with D-period like banding pattern
In our lab, we created a new collagen mimetic peptide called Col108. Col108 was obtained
from a recombinant gene expressed in E. coli. The sequence of Col108 has 417 residues that
include triple helix domain and foldon domain (27 residues) (Figure 1-6). The triple helix domain
has three repeating units named U1, U2 and U3 respectively. In each unit, there is a 108-residue
col domain and a N-terminal (Gly-Pro-Pro)4 sequence. The 108 residues of the col domain were
taken from different regions of α1 chain of human type I collagen: residue 242 to 256, 296 to 322,
434 to 478, 515 to 535. These residues were selected based on their relatively high propensity for
triple helix stabilization according to the work of Brodsky’s lab (39). A Cys-knot sequence
consisting of Gly-Pro-Cys-Cys was incorporated at N-and C-termini of the triple helical domain
to covalently link the three polypeptide chains of a triple helix through a set of interchain disulfide
bonds (40). The C terminal 27-residue-long fodon domain taken from bacteriophage T4 fibritin
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was included as a nucleation domain during the folding of the triple helix.

Figure 1-6 The sequence of Col108. Grey boxes are restriction enzyme sites. The three sequence units
are marked by the double-head arrows. Numbers above the residues indicate the positions of residues in
human α1(I) chain. (taken from Kaur et al (40)).

The self-assembled Col108 mini-fibril was characterized by an axial periodicity of 35 nm
(40). The banding pattern in Col108 fibrils is similar to that of natural type I collagen. Under
electron microscope, the overlap zone (light band) is ~ 10 nm and gap zone (dark band) is ~ 25 nm
in negatively stained Col108 fibrils (Figure 1-7). The 35 nm d-period of Col108 is consistent with
a one-unit staggering arrangement of Col108 triple helices in the mini-fibrils. A sequence unit of
Col108 is about 123 residues including the col domain and the (GPP)4 insert. In the linear
conformation of the triple helix having a uniform helix rise of 0.8 – 0.9 nm per Gly-X-Y triplet, a
123 residue segment correlates to a ~ 35 nm segment, highly agreeable with the observed dperiodicity of the mini-fibrils (40). The predicted one-unit staggered pattern of Col108 mini-fibril
is shown in Figure 1-8. In this model, the sequence units of the associating triple helices are in
register, thus the hydrophobic residues of one triple helix have potential to interact another
hydrophobic residues of the neighboring triple helices. While the charged residues interact only
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with those having an opposite charge, the characteristic sequence placement of Col108 having
clusters of oppositely charged residues next to each other can potentially create zones of charged
residues and ultimately reinforce the electrostatic interactions between the helices. Thus, the oneunit staggered pattern brings residues in optimal alignment to maximize the interactions between
associating triple helices and makes the d-periodic mini-fibrils the unique, most stabile
conformation.

Figure 1-7 The TEM pictures of Col108 mini-fibrils. A, the negatively stained mini-fibrils after 6h incubation
at 37 °C. B, the negatively stained mini-fibrils after 24 h incubation at 37 °C. (taken from Kaur et al (40)).

Figure 1-8 Col108 mini-fibril model showing charge distribution. The three sequence units of the peptide
are separated by black vertical bar; Blue vertical bars show positive charge residues; Red vertical bars
show negative charge residues; The oval represents foldon domain.
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Although Collagen mimetic peptide Col108 self-associate into mini-fibrils with d-banding
periodicity, we still do not know what the determining factor for self-assembly of Col108 is. My
thesis work focuses on the hypothesis that the periodicity of Col108 mini-fibrils is instigated by
the repeating sequence units of Col108. We propose that a one-unit staggered arrangement of the
triple helices would maximize both the hydrophobic and electrostatic interactions of associating
helices and thus, stabilize the fibrils. I plan to test this hypothesis by studying the minimum number
of repeating sequence units and investigating the roles of the sequence architecture.
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Chapter 2. The d-periodic mini-fibrils of collagen mimetic peptide Col108

2.1 Introduction
Previous studies in our lab lead to the discovery of the self-assembly of Col108 to form mini-fibrils
having a 35 nm axial repeating structure similar like that of the 64 nm D-period of fibrillar collagen.
We call this axial structure of Col108 mini-fibrils the d-period. A previous work on the
characterization of mini-fibrils by analytical centrifugation (AUC) demonstrate that molecular
weight average of the Col108 samples in TES buffer drastically increased. This AUC data supports
Col108 self-assemble in solution during fibrillogenesis other than in dry condition (40). I started
my work on the further characterization of the structure of the Col108 mini-fibrils using TEM,
atomic force microscopy and cryo-EM.

2.2 Methods and materials
2.2.1 The expression and purification of Col108
Col108 was expressed in Escherichia coli strain BL21(DE3) using a customary pET32a(+)
plasmid which carries the His-tagged thioredoxin-Col108 fusion protein (Trix-Col108). The fusion
protein was first purified using Ni-NTA metal affinity resin (Qiagen Cat# 30210). The His-tagged
thioredoxin was subsequently removed by thrombin cleavage, and separated from Col108 by
reverse phase high-performance liquid chromatography (RP-HPLC). Some details of the
purification procedure are described in reference (40).
During the first inoculation of the purification, a colony from the ampicillin plate of
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transformed BL21(DE3) cell was picked and grew in 10 mL LB medium containing 0.05 mg/mL
antibiotic ampicillin (Amp+) overnight in the shaker at 200 rpm at 37°C. Then, the 10 mL cell
culture were grown in 1 L LB media containing 0.05 mg/mL Amp+ at 37°C until OD600 reached a
value of 0.6. The expression of protein was induced by adding 100 µL of 2 M isopropyl-b-D
thiogalactoside (IPTG) to a final concentration of 0.2 mM IPTG. The culture was, subsequently
incubated at 25°C in the shaker at 200 rpm overnight (around 16 h).
The cells of one liter liquid culture were harvested by centrifugation at 5000 rpm for 20
min at 4°C (Beckman Coulter centrifuge with JA-12 conical rotor, serial #03U1169). The
supernatant media was removed and cell pellet was transferred into a 50 mL disposable centrifuge
tube. The cell pellets were resuspended in 20 mL of pre-chilled pH 7.4 wash buffer (50 mM Tris,
300 mM NaCl). 1 mL of 20 mg/mL of fresh prepared lysozyme solution was added to lyse cell
walls.
To prevent the proteolysis of protein, 200 µL of 1 M PhenylMethlySulfonyl Fluoride
(PMSF) freshly made solution was added into cell lysate to a final concentration of 0.2 mM. 4 µL
of 5 kU Pierce™ Universal Nuclease (Cat# 88700) was also added to degrade DNA. The cells
were ruptured by sonication under cooling (Vibracell, six 60 second pulses, machine output 3, duty
cycle 30%, microtip limit 4). The cell lysate was spun down at 10000 rpm for 20 min at 4 °C with
JA-12 conical rotor. After centrifugation, the supernatant was poured gently into a 50 mL
centrifuge tube. The resin was prepared by taking 4 mL of re-suspended Ni-NTA agarose resin
slurry into a gravity flow Column (Fisher, Cat# K420401-1505). The resin was washed three times
(50 mM Tris, 300 mM NaCl, pH 7.4). The resin was then added into the centrifuge tube containing
cell lysate sealed with parafilm. The mixture was agitated at 4°C for 3 hours for His-tagged protein
binding to the resin. And then the mixture was transferred into that gravity flow column. After the
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resin was settled in the column, the supernatant was taken out from the top and labeled as nonbinding sample.
The resin in the column was first washed using 20 mL wash buffer containing 50 mM Tris
and 300 mM NaCl (pH 7.4). The resin in the column was washed the second time by 20 mL wash
buffer containing 10 mM imidazole (pH 7.4). And then the resin was washed the third time by 20
mL wash buffer including 20 mM imidazole. The fusion protein was then eluted by 10 mL elution
buffer (50 mM Tris, 300 mM NaCl and 300 mM imidazole, pH 7.4), and collected in fractions.
Every fraction has around 1 mL.

The collected samples were analyzed by running 12%

polyacrylamide gel electrophoresis following the protocol in reference (41).
The eluted fractions showing target protein were pooled together about 7 mL. Combined
sample was dialyzed against 50 mM Tris, 300 mM NaCl wash buffer with a pH of 7.4 to remove
imidazole. The dialysis was carried out by using dialysis cassette (ThermoFisher Scientific Cat #
66110) in 4°C refrigerator. The buffer was changed once after around 4 hours and then left
overnight at 4°C. The ratio of the volume of dialyzed sample and dialysis buffer was 1: 100.
After dialysis, the sample was cleavage using thrombin enzyme. The powder form of
human Thrombin enzyme was purchased from Thermo Fisher (Cat number T6884). Each vial
contains 120.4 NIH units of the enzyme, and each NIH unit equals to 0.324 μg of the enzyme
(120.4 NIH=39 μg). The enzyme was dissolved in 100 μL of 50 mM Tris, 150 mM NaCl (pH 7)
buffer. Based on the instruction manual, cleavage of fusion proteins can be carried out at a
thrombin to fusion protein ratio of 1:500. One vial of human thrombin enzyme powder can cleave
~19 mg of protein. 20 μL dissolved thrombin was added into ~ 7 mL dialyzed sample and left at
4°C refrigerator for 24 h. The cleaved sample was run on a 12% polyacrylamide gel to if fusion
protein was cleaved completely.
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Cleaved protein and His-tagged thioredoxin were separated by high-performance liquid
chromatography (Beckmann Coulter System Gold 126 solvent module, detector 168 , SC100
fraction collector running 32 Karat 7.0 software) with reverse phase C8 preparative column (Vydac
Cat# 208TP1010). 5 mL of the 7 mL combined sample was run using a time program graph where
the initial acetonitrile gradient changes from 5% to 30% is done in 15 minutes followed by the
gradient change from 30% to 45% in 30 minutes (0.5% per minute) and from 45% to 70% in 25
minutes (1% per minute). The elution gradient created for Col108 separation is shown (Figure 21). The 50 elution fractions were collected every 40 seconds after 22 nd minute of the run. The
presence of protein in collected fractions was confirmed using 12% SDS-PAGE. The small portion
of sample (~ 80 μL) were taken from each collected fraction sample and left at vacuum to dry for
3 days. The fractions that have the protein were pooled together and lyophilized, and stored as
lyophilized powder.
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Figure 2-1 Time program graph used for preparative column with percentage gradient acetonitrile.

2.2.2 Preparing Col108 solutions
The lyophilized protein powder was dissolved in 5 mM Acetic Acid (pH 4) to a final
concentration of 1 mg/mL. The concentration was determined using NanoDrop 1000
Spectrophotometer with extinction coefficient of 0.232 for Col108 at 280 nm. The extinction
coefficient

of

Col108

proteins

was

calculated

by

ProtParam

online

tool

(https://web.expasy.org/protparam/). The samples were equilibrated in 4°C refrigerator for 7 days.
2.2.2 Conformation Studies
All CD experiments were performed using AVIV CD spectrometer (Biomedical, Model
202-01) with a temperature control system (a thermal controller Thermo Neslab Merlin M33
connected to a water bath), and quartz cuvettes with 1 mm optical path. Spectra were taken at 4°C,
wavelength range 190 – 300 nm. Ellipticity measurements were corrected for buffer baseline using
the same cuvette. CD data were analyzed using the Origin software. The raw CD data (in
millidegree) are normalized to mean residue molar ellipticity (MRE):

[𝜃 ] =

𝜃 × 𝑚
𝑐 × 𝑙 × 𝑛+

𝜃 is the ellipticity in millidegree. 𝑚 is the molecular weight in g/mol. 𝑐 is the concentration in
mg/ml. 𝑙 is the path length of the cuvette in mm. 𝑛+ is the number of amino acid residues in the
peptide.
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2.2.3 Thermal stability studies
Thermal stability is determined using temperature melt experiment. The thermal melting
profiles were obtained by monitoring CD value at a wavelength of 225 nm, as the temperature was
increased from 4 °C to 65 °C and equilibration time of 2 min at each temperature (equivalent to an
average heating rate of 0.3 °C/min). The fraction of folded sample was calculated based on the
equation in Reference (42). The equation for calculation of fraction of folded is shown below:

Fraction of folded =

𝜃89:;+<;= − 𝜃?8@8?;+
𝜃A+B?;+ − 𝜃?8@8?;+

𝜃 observed is observed ellipticity. 𝜃 trimer is calculated from the best linear fit equation for the trimer
part of the melting curve. 𝜃 monomer is calculated from the best linear fit equation for the monomer
part of the melting curve.
2.2.4 Fibril formation
To start fibril formation, Protein samples at 1 mg/ml in pH 4 buffer at 4°C were mixed with
an equal volume of pre-chilled, double strength neutralization buffer (60 mM TES, 60 mM
Na HPO , and 135 mM NaCl, pH 7.4). Thus, the final concentration of Col108 was 0.5mg/mL and
2

4

the final composition of the fibrillogenesis buffer after mixing was 2.5mM acetic acid, 30 mM
TES, 30 mM Na2HPO4, and 67.5mM NaCl, pH 7.4 (I= 0.09); this buffer will be called TES buffer
for later discussion. Col108 in TES buffer was incubated in water bath at 37°C for 24 h. All
solutions and buffers were made using ultrapure water.
2.2.5 TEM characterization of Col108 mini-fibrils
To prepare for TEM: After incubation at 37 °C, 3 µL of incubated sample was placed on a
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400 mesh formvar carbon-coated copper grid (Electron Microscopy Sciences, Cat # FCF400-Cu).
After 1 min, the grid was drained slowly with filter paper. And then 6 µL of 1% sodium
phosphotungstate (the staining solution) was immediately added on the grid, after 4 min, excess
staining solution was removed using filter paper, and then rinsed with deionized water. The grid
was air-dried for at least one hour and then examined by Zeiss 902 electron microscopy or JEM2100 electron microscope (Jeol Corp.) to visualize the morphology of higher order structures.
2.2.6 AFM characterization of Col108 mini-fibrils
For tapping mode AFM imaging, samples were prepared on a freshly peeled mica support.
The upper layer of mica was peeled using a piece of standard Scotch tape. This step was repeated
a couple times until we have a nice layer of mica on the tape indicating an entire layer of mica was
exfoliated. And then 10 µL protein sample was added on the mica surface as soon as possible
because if the fresh mica is exposed it starts reacting with air. The sample was incubated on mica
for 2 min at room temperature and rinsed with 10 mL ultrapure water. After that the sample was
dried quickly with Nitrogen gas (at least for 5 min). The mica supports were sent to Dr. Laurent
Kreplak’s lab (Department of Physics and Atmospheric Science, School of Biomedical
Engineering, Dalhousie University, Halifax, Canada) for imaging. All the imaging was carried out
using a tapping mode AFM and scanner (Agilent 5500). All image analysis and measurements
were performed using SPIP 6.3.3 software (Image Metrology). The work was done in collaboration
with Dr. Kreplak’s lab.
2.2.7 Cryo-EM characterization of Col108 mini-fibrils
The Cryo-electron microscopy (cryo-EM) study was carried out in ASRC CUNY, in
collaboration with Dr. Tong Wang. Cryo-EM grids were prepared in an FEI Vitrobot at 20 °C with
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the relative humidity set to 100% and the blotting force set to zero. The samples (3 µL) of peptides
after incubation in TES buffer were pipetted onto a freshly glow-discharged 400 mesh lacey carbon
grid (TED PELLA INC. Cat#01824). The sample solution was incubated on the EM grid for 2
minute, blotted for 4.5 seconds before being plunged into liquid ethane that was pre-cooled by
liquid nitrogen. The cryo-EM grids were then transferred to and stored in liquid nitrogen. When
needed, they were transferred in liquid nitrogen into a Gatan 626 cryo-specimen holder and then
inserted into the microscope. The specimen temperature was maintained at −170 °C during the
data collection. Cryo-EM imaging was performed in an FEI TITAN Halo TEM operating at 300
kV.
2.2.8 Sample preparation of commercial collagen
Commercial collagen (type I collagen from rat tail, Sigma-Aldrich C7661) was first
dissolved in 5 mM acetic acid to concentration of ~ 1 mg/mL and then mixed with the same volume
of double strength neutralization buffer. The sample was prepared for fibril formation with the
same procedure of Col108. The difference is that commercial collagen in TES buffer was
incubated in water bath at 37°C for 2 h. The EM grids were prepared as described for Col108.
2.3 Results
2.3.1 The purification of Col108
The purification of Col108 is shown in Figure 2-2. The fusion Col108 monomer band
(black box) and fusion Col108 trimer band (purple box) were seen in samples taken before dialysis
and taken after dialysis. The position of fusion Col108 monomer and trimer are usually higher than
their expected molecular weight position. After thrombin cleavage, fusion Col108 monomer band
and fusion Col108 trimer band disappeared, and Col108 monomer band (red box) and Col108
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trimer band (green box) were seen on the gel. 52 kDa fusion Col108 monomers (fusion Col108
trimer ~156 kDa) were efficiently cleaved into 38.3 kDa Col108 monomers (Col108 trimer ~114.9
kDa) by thrombin enzyme. On the gel, the migration of Col108 bands does not correlate with their
molecular weights markers because triple helical protein is rod-like structure, and moves
differently from globular proteins. The position of globular protein thioredoxin (13.7 kDa)
highlighted by yellow box in lane 5 of Figure 2-2 is near its expected molecular weight position
on the gel. There are additional bands presumably due to the nonspecific binding of Ni-NTA resin.
We saw the bands of Trix-Col108 trimer and Col108 monomer on the gel because the reduction
of protein trimers using reducing agent DTT is not complete and some triple helices are crosslinked through disulfide bonds.

Figure 2-2 SDS-PAGE (12%) analysis of thrombin cleavage of Col108 fusion protein. Samples before
cleavage are in lane 3 and 4. Sample after cleavage is in lane 5. Lane 1 and 2 are high range protein
makers and low range protein makers, respectively. Black box and purple box respectively highlight Col108
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fusion protein monomer and trimer. Red box and green box respectively highlight Col108 monomer and
trimer form. Yellow box labels thioredoxin.

After separation from the His-tagged thioredoxin using HPLC, the purified Col108 was
confirmed by SDS-PAGE (Figure 2-3); only Col108 monomer (red box), dimer and trimer (green
box) bands were seen on the gel. The molecular weight of His-tagged thioredoxin and thrombin
enzyme are ~ 13.7 kDa and ~ 37.4 kDa, respectively. No bands that correlate with thrombin
enzyme are present on the gel. The gel in Figure 2-3 was over-run. We have other data indicating
that thioredoxin band is not present in these samples. No other contaminants are shown either. This
result demonstrates that the protein sample was very pure.
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Figure 2-3 SDS-PAGE (12%) analysis of fraction samples after HPLC separation. Lane 1 – 7 are fraction
samples (15- 21) after collection starting at 22 min. Red box highlights the position of Col108 monomer.
Green boxes label the position of Col108 trimer and dimer.

2.3.2 Characterization of Collagen-Mimetic Peptide Col108
The triple helix conformation of collagen is characterized by a positive maximum peak at
225 nm and a deep negative peak at 197 nm on a CD spectrum (43). Lyophilized Col108 powder
was dissolved in 5mM Acetic Acid (HAc, pH 4) at a concentration of ~ 1 mg/mL. The sample was
equilibrated about one week in 4°C refrigerator to form triple helix structure. The concentration
used for CD is diluted to 0.4 mg/mL. The triple helix conformation of Col108 was confirmed by
the CD spectrum showing a small positive peak at 225 nm and a deep negative peak at 197 nm at
4°C (open circle, Figure 2-4). When temperature was increased to 47°C, CD spectrum of Col108
resembled that of a random coil having a shallow negative peak ~ 190 nm, and no positive peak at
225 nm (filled circle, Figure 2-4). The Col108 is unfolded at this temperature and there is no triple
helix conformation in Col108 at 47°C.
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Figure 2-4 CD spectra of Col108. CD spectra of 0.4 mg/mL Col108 in 5 mM acetic acid were respectively
taken at 4°C (open circle) and 47°C (filled circle).

2.3.3 The thermal stability of Col108
The temperature induced change of CD signal at 225 nm which is the characteristic
maximum for triple helix was used to study the thermal stability of Col108. As Col108 sample is
heated, the mean residue ellipticity decreases indicating a transition from triple helices to random
coils. The concentration of the sample used for this study is 0.4 mg/ml Col108, with a temperature
range from 4°C to 65°C. The melting temperature (Tm) which is the temperature at the mid-point
of the transition, was determined to be 41°C (Figure 2-5). This result suggests that Col108 triple
helix is stable at 37°C (the incubation temperature) during mini-fibril formation.
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Figure 2-5 CD melting curve of Col108 triple helix from 4°C to 65°C. The thermal unfolding of Col108 triple
helix was monitored by at 225 nm, and normalized to fraction of folded.

2.3.4 The d periodicity of mini-fibrils of Col108 characterized by TEM
In order to better understand the nature of the d-periodic mini-fibrils I first studied the Dperiodic fibrils of natural collagen using TEM. The cross-striated type I collagen fibrils with 67
nm D-period were observed under Zeiss 902 electron microscopy (Figure 2-6). The D-period
includes ~ 27 nm the overlap region (light band) and ~ 40 nm gap region (dark band). The fibrils
are ~ 60 nm to ~ 120 nm in diameter. The length of fibrils is difficult to identify because the fibrils
are very long and overlapped under TEM.
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The axial repeating structure of Col108 mini-fibrils looked very much like that of the Dperiod of natural collagen fibrils when examined using TEM, but smaller in size. The banding
patterns of Col108 mini-fibrils were clearly observable under JEM-2100 electron microscopy
(Figure 2-7). The periodicity of banding pattern is ~ 35 nm estimated from the negatively stained
fibrils: including a dark band of ~ 25 nm and a light band of ~ 10 nm. The periodic mini-fibrils
examined using TEM are ~800 nm to ~ 1 µm in length and ~ 50 nm to ~ 75 nm in diameter.

Figure 2-6 The TEM images of type I collagen fibrils from rat tail. (A-B) the negatively stained commercial
collagen fibrils after 2 h incubation at 37 °C. The magnifications are 5000 X and 3000 X, respectively.
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Figure 2-7 The TEM images of Col108 mini-fibrils. (A-B) the negatively stained mini-fibrils after 24 h
incubation at 37°C. Both magnifications are 10000 X.

2.3.5 The d periodicity of mini-fibrils of Col108 characterized by AFM
The study of the Col108 mini-fibrils by AFM were carried out in collaboration with Dr.
Laurent Kreplak’s lab in Canada. Three micas of Col108 were prepared and the surface of micas
were examined by AFM. All of three micas showed plenty of mini-fibrils with d periodicity. The
topography images of Col108 fibril samples after 24 hours of incubation at 37°C are shown in
Figure 2-8. The mini-fibrils have similar morphological features to those observed using TEM. In
the AFM micrographs, the mini-fibrils are ~ 800 nm to ~ 1 µm in length and ~ 25 nm in diameter
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according to the scale bar. The diameter of mini-fibrils in AFM micrograph is smaller than that in
TEM micrograph. The TEM image is not high resolution and involved a lot of staining. The
diameter of mini-fibrils measured by AFM is more reliable. The d-periodic band of mini-fibrils is
strongly apparent in the phase channel, compared with height image. The d-periodicity banding
pattern is estimated ~ 35 nm observable in AFM images. These AFM data support that Col108
under appropriate condition forms cross-striated mini-fibrils with d-periodicity.

Figure 2-8 AFM topography images of Col108 mini-fibrils. Acquired height and phase images are of Col108
in TES buffer deposited onto freshly split mica. Scale bar is 500 nm.

2.3.6 Col108 mini-fibrils characterized by cryo-EM
Cryo-EM is a technique to prepare samples in a more native-like hydrated state. In the
preparation, the protein samples were brought to the solid state without dehydration by fast
freezing, and the sample was maintained at low temperature during transferring and observation
in the EM (44). I examined six grids made from different solutions and two purification samples.
There are no discernable mini-fibrils and single triple helices on the first two of grids observed by
32

cryo-EM. It may be caused by low concentration of Col108 mini-fibrils samples. I concentrated
the Col108 samples in TES buffer from another protein purification by centrifugation at 2000 rpm
for 5 min and taking samples from the bottom. Four grids were made for cryo-EM examination.
Many flattened bundles of single triple helices are observed in cryo-EM micrographs (Figure 2-9).
We think the mini-fibrils had formed, but fell apart during freezing to create the imaged flattenedbundles of triple helix. The dissociation of Col108 mini-fibrils might be induced by the degradation
of mini-fibrils by freezing ((45), personal communication with Dr. Joachim Frank). Finding a way
to stabilize the mini-fibrils during fast freezing is a solution to improve the characterization of
mini-fibrils by cryo-EM. We are planning to continue this work in collaboration with Dr. Tong
Wang at CUNY ASRC.

Figure 2-9 Cryo-EM image of Col108 aggregates. Scale bar is 200 nm.
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2.4 Summary
The self-assembly of collagen mimetic peptide Col108 into higher order structure under
appropriate conditions using TEM, AFM and cryo-EM. The prerequisite of fibril formation is that
Col108 forms triple helical structure. The data of thermal stability indicate that Col108 triple helix
is stable at fibril formation temperature. The AFM data reproduced the earlier findings (40) but at
higher resolution, and with better quality. The cryo-EM appeared to capture the disassembly of the
mini-fibrils. We are working to find a way to stabilize the mini-fibrils or different freezing
approaches for further investigation.
While this part of the work confirmed the self-assembly of Col108 mini-fibrils, the
mechanism of the fibril assembly is not clear. We need to explore if the repeating sequence unit is
a crucial factor for periodic mini-fibrils and what the minimum number of repeating units for the
self-assembly of the d-period fibrils is. The major part of my thesis focused on addressing these
two questions.
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Chapter 3. The self-assembly of a triple helix with two sequence units –
the sufficient conditions for the formation of mini-fibrils with the d-period
3.1 Introduction
3.1.1 Sequence design of 2U108 and 1U108
The study of Col108 have shown that, under appropriate buffer condition, Col108 selfassembles into mini-fibrils possessing the characteristic 35 nm d-periodicity through a unitstaggered arrangement (2). The triple helix of Col108 has a built-in sequence periodicity that
contains three pseudo-identical repeating sequence units. A unit-staggered model was proposed to
indicate that because of the identical, repeating sequence units, a mutual staggering of onesequence unit of associating triple helices represent the unique, most stable structure of selfassembly. Based on the unit-staggered model, peptide with two units should self-assemble into
mini-fibrils with the same periodicity of Col108 mini-fibrils. While peptide without any longrange repeating sequences will not be able to form the d-staggered mini-fibrils.
Two new peptides 2U108 and 1U108, consisting of, respectively, two and one sequence
repeats were generated for this study. The gene constructs of 2U108 and 1U108 were generated
by a graduate student (Sam Wong) in our lab using the original Col108 plasmid in reference (46).
The schematic diagram of the generation of the expression constructs is shown in Figure 3-1.
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Figure 3-1 The construct of 2U108 and 1U108. For generating 2U108, the second collagenous unit and
(Gly-Pro-Pro)4 were removed. The third collagenous unit and (Gly-Pro-Pro)4 were deleted from 2U108 to
make 1U108. Cysteine knots (purple), (Gly-Pro-Pro)4 (green), Col108 domain (blue) and foldon domain
(red) are highlighted in box. The restriction enzyme sites (BamHI, XbaI, KpnI and EcoRI) are shown by
black arrows.

The whole amino acid sequence of 2U108 and 1U108 are shown in Figure 3-2 and Figure
3-3, respectively. Collagen mimetic peptide 2U108 contains 294 amino acid residues that includes
two identical sequence units in tandem with a nucleation domain, a sequence for Cys-knot (GlyPro-Cys-Cys) at both the C- and the N- termini of the triple helix domain and a C-terminal foldon
domain. Peptide 1U108 contains 174 amino acid residues that is composed of one sequence unit
((Gly-Pro-Pro)4 and Col-domain) with a nucleation domain, a sequence of (Gly-Pro-Cys-Cys)
incorporated at both ends of triple helical domain and foldon domain at C-terminus. The main
difference between 2U108 and 1U108 sequence is that 2U108 has two repeating sequence units
and 1U108 only have one repeating sequence unit. The cysteine residues are used to form
interchain disulfide bonds to link peptide monomer chain together to form triple helix structure.
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The foldon domain at C terminus serves as trimerization domain for triple helix folding. 2U108 is
a 27 kDa triple helical peptide. 1U108 is a 16 kDa triple helical peptide, comprised of a singular
sequence unit, with a C-terminal foldon domain.

Figure 3-2 The amino acid sequence architecture of 2U108. (I) The overall sequence architecture of 2U108.
The repeating sequence units are marked with double headed arrows. The amino acid sequence of the Col
domain is shown in an expanded view. The residues introduced by restriction enzyme sites are highlighted
by red box. The cysteine knots are shown in pink, (Gly-Pro-Pro)4 in green, and foldon in red, respectively.
(II) The entire amino acid sequence of 2U108, with the cysteine knots, (Gly-Pro-Pro)4 and foldon highlighted
in pink, green and red, respectively.
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Figure 3-3 The amino acid sequence architecture of 1U108. (I) The overall sequence architecture of 1U108.
The repeating sequence units of 1U108 are marked with double headed arrows. The amino acid sequence
of the Col domain is shown in an expanded view. The residues introduced by restriction enzyme sites are
highlighted by red box. The cysteine knots are shown in pink, (Gly-Pro-Pro)4 in green, and foldon in red,
respectively. (II) The entire amino acid sequence of 2U108, with the cysteine knots, (Gly-Pro-Pro)4 and
foldon highlighted in pink, green and red, respectively.

3.2 Materials and Methods
The expression and purification of 2U108 and 1U108 were under the similar conditions as
for with Col108 as described in chapter 2 and in reference (40). The extinction coefficient of 0.322
for 2U108 and 0.538 for 1U108 at 280 nm are calculated using the online tool Protparam. The
characterization, including the folding, the thermal stability study, and fibril formation, and the
characterization using TEM are all described in Materials and Methods of Chapter 2 and in
reference (40).

3.3 Results
3.3.1 The triple helical peptides 2U108 and 1U108
The samples were examined using circular dichroism spectrometer (CD) to check for the
conformation of triple helix. The proteins were equilibrated to ensure the folding into triple helix.
1 mg/mL equilibrated proteins solution were diluted to 0.4 mg/mL or 0.5 mg/mL for examining
the folding. CD spectra of 2U108 and 1U108, recorded from 300 nm to 190 nm, show typical triple
helical spectra with a positive peak at 225 nm and a minimum peak at 197 nm (Figure 3-4). We
diluted a stock solution of 1U108 of ~ 1mg/mL in acetic acid buffer to 0.5 mg/mL to test the
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folding. Because we did not have enough 2U108 sample for the study of fibril formation, we did
not dilute the 1mg/mL 2U108 solution to 0.5 mg/mL. The data of Col108 triple helix is included
for comparison. The Rpn values (the ratio of the value of positive peak to that of the negative peak)
of 2U108 (~ 0.09) and 1U108 (~ 0.09) are comparable to that of Col108 (40).
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Figure 3-4 Circular dichroism spectra of 2U108 and 1U108. CD spectra of Col108 (open black circle),
2U108 (red square) and 1U108 (blue triangle) in 5 mM acetic acid were taken at 4°C. The concentration of
Col108, 2U108 and 1U108 are 0.4mg/mL, 1mg/mL and 0.5 mg/mL, respectively.

The thermal stability of 2U108 and 1U108 was estimated to be 41°C (Figure 3-5) for both
peptides. The thermal stability of Col108 is around 41°C and included for comparison. These three
peptides have different size, and different number of amino acid residues, but their thermal
stabilities are similar. Thermal stability depends on amino acid sequence but no direct relation to
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the length of peptides, when the peptide is larger than 45 residues (33,47). Thermal stability of
human type I collagen is ~ 37°C and contains hydroxyproline in the Y position of (Gly-X-Y)n
tripeptide (48). Foldon domain at C- terminal end of the mimetic peptides, cysteine knots at both
ends of triple helix domain and the high content of the charged residues may contribute to the
increased thermal stability (49). The measurement of conformation and thermal stability of these
two collagen mimetic peptides indicate both peptides are sufficiently stable for the study of selfassembly.
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Figure 3-5 Temperature melting curve of Col108, 2U108 and 1U108 in 5mM acetic acid from 4°C to 55°C.
The concentrations of Col108, 2U108 and 1U108 are 1 mg/mL. The thermal unfolding of Col108 (open
black circle), 2U108 (red square) and 1U108 (blue triangle) triple helices was monitored by at 225 nm, and
normalized to fraction of folded.
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3.3.2 Self-assembly of mini-fibrils
First, I studied the self-assembly of 2U108. For TEM examination, 20 grids were prepared
from one purification of 2U108. Under electron microscopy, we observed that 2U108 formed
smooth mini-fibrils, similar to those observed for Col108 (40). The mini-fibrils are about 500 nm
to 1 µm in length and ~ 25 nm to ~ 75 nm in the diameters of the central part of the mini-fibrils.
The images of 2U108 mini-fibrils shown in Figure 3-6 were examined by Zeiss 902 electron
microscopy (City College, CUNY). The banding pattern of these mini-fibrils are visible, but
cannot be clearly measured because the resolution of these images is low. To get a better resolution
of the structure, I moved on to use JEM-2100 electron microscopy. I prepared 10 grids from
another purification of 2U108. Under high resolution TEM, it is clear that 2U108 mini-fibrils have
the same 35 nm d-periodicity as that of Col108. The light band (overlap region) is ~ 10 nm and
dark band (gap region) is ~ 25 nm in negatively stained 2U108 fibrils (Figure 3-7). The TEM
image of 2U108 in 5 mM acetic acid before transferring to the TES buffer was also examined for
comparison (Figure 3-6(F)). This image shows a uniform background of 2U108 triple helices with
no mini-fibrils. 2U108 single triple helix is expected to be ~ 85 nm in length and ~ 1-2 nm in
diameter. Some 2U108 monomers may exist according to the size of the structure.
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Figure 3-6 The TEM images of 2U108. (A-B) the negatively stained 2U108 mini-fibrils after 24 h incubation
at 37 °C at the magnification of 30000 X. (C-D) the negatively stained 2U108 mini-fibrils after 24 h incubation
at 37°C at the magnification of 50000 X. (E) the negatively stained 2U108 mini-fibrils after 24 h incubation
at 37°C at the magnification of 20000 X. (F) the TEM image of 2U108 in 5mM HAc.

Figure 3-7 The TEM images of 2U108 mini-fibrils. A-B, the negatively stained 2U108 mini-fibrils examined
by JEM-2100 electron microscopy after 24 h incubation at 37°C at the magnification of 10000 X.
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For the study of 1U108, I prepared ~ 20 grids from two different purifications of 1U108
and examined them using Zeiss 902 electron microscopy. No fibril-like assembles were found in
any grids (Figure 3-8). A 1U108 triple helix is expected to have a length of about 50 nm, and ~ 12 nm in diameter. Some aggregates of 1U108 formed in different shapes can been seen via TEM.
These aggregates are thicker than single 1U108 triple helical molecule and ~ 200 nm in length.
They are likely formed by lateral association of the triple helices, but do not follow any specific
pattern. Compared to the TEM images of 2U108 at the same magnification, the size of 1U108
aggregate is smaller than that of 2U108 mini-fibrils. Because of the lack of any specific,
identifiable structural features of the aggregates of 1U108, we consider them as non-specific
aggregates.
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Figure 3-8 The TEM images of 1U108. (A-B) the negatively stained aggregates after 24 h incubation at
37 °C at the magnification of 30000 X. (C-D) the negatively stained aggregates after 24 h incubation at
37 °C at the magnification of 50000 X.
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3.4 Summary
The unit-staggered model requires a triple helix with at least two repeating units like 2U108
to produce mini-fibrils with the d-period. One-unit staggered arrangement maximizes the
interactions between the associating helices by optimal alignment of interacting residues to
stabilize the staggered structure, and thus, makes the arrangement the most stable structure
compared to other staggered arrangements. As expected, our results show collagen mimetic
peptide 2U108 with two repeating sequence units self assembles into mini-fibrils with 35 nm dperiodicity. The formation of the 2U108 mini-fibrils demonstrated that there are robust interactions
between repeating sequence between the associating helices during to support one-unit staggering
self-assembly mechanism. In contrast, 1U108 which has only one sequence unit failed to form any
fibril assemblies having the d-period. The interactions between triple helices of 1U108 might lead
to different kinds of aggregates without periodic banding pattern. The d-periodic mini-fibrils of
2U108 offers an alternative sequence architecture to design new collagen mimetic peptide. Being
smaller, 2U108 also appears to have higher expression yields and improve the efficiency of our
research. The finding of 2U108 and 1U108 confirmed our understanding of Col108 d-periodic
mini-fibrils. In the next, we will study if any specific residues of the tandem repeating units play
deterministic roles in the self-assembly of the collagen mimetic peptide.
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Chapter 4. Self-assembly of triple helical peptides Col877 and Col108R

4.1 Introduction
Col108 having three repeating sequence units and 2U108 having two repeating sequence
units self-assemble into identical mini-fibrils with d-periodicity, while 1U108 with one sequence
unit does not. The length of triple helix formed by one sequence unit of Col108 and 2U108 is
approximately 35 nm (d-periodicity). The unit-staggered arrangement explains the size of the
overlap and gap region of mini-fibrils. At least two repeating units are necessary for the unitstaggered model to form periodic mini-fibrils. Col108 and 2U108 share the same repeating
sequence unit- the (Gly-Pro-Pro)4-Col-domain. To further understand the involvement of specific
residues in the Col-domain during the self-assembly of Col108 and 2U108, we created two new
collagen mimetic peptides.
Col108R which has the same amino acid composition of that of Col108 but lacks the
sequence periodicity; and Col877 which has the same repeating sequence architecture of that of
Col108 but has a completely different sequence in each repeating sequence unit. Based on our oneunit staggered arrangement, Col877 with three repeating sequence units may self-associate to minifibrils with d-periodicity. Col108R which does not have sequence periodicity should not form
fibrils.

4.2 Methods and Materials
4.2.1 The genes of Col877 and Col108R
The genes of Col877 and Col108R were synthesized with two restriction enzymes sites
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BamHI and EcoRI at 5’ and 3’ ends, respectively, by GenScript Corporation. The genes were
codons optimized for bacterial expression. We provided the expression plasmid. The synthesized
genes were directly cloned into the expression vector pET32a(+) using a 5’ BamHI and a 3’ EcoRI
restriction enzymes. The sequences of the genes were confirmed by GenScript Corporation
(Appendix). After we received the plasmids, we double checked the sequence of the genes. The
plasmids were transformed into DH5α E. coli competent cells (Invitrogen) and purified using
Wizard Plus SV Minipreps DNA purification kit (Promega Cat# A1330). The concentration of
plasmids was measured using Nanodrop 1000 Spectrophotometer (Thermo Scientific). The ratio
of 260/280 is ~ 1.9. The Col877 plasmid was sequenced using the forward primer of T7 promotor
and the reverse primer of T7 terminator (provided by Genewiz Corp.). The Col108R plasmid was
purified

and

sequenced

using

two

synthesized

primers:

primer

5’-

ATCCGTGGTATCCCGACTCT-3’ and primer 5’-GGGCGATACCGGCCCGGA-3’ targeting
thioredoxin region and second repeating sequence unit region, respectively. Both primers were
synthesized by Macrogen Corporation and the sequencing was done by Macrogen. Upon receiving
the sequence results, the DNA sequencing data were further analyzed and confirmed using bioedit
software. The products of the genes were fusion proteins in the form of His-tagged thioredoxinCol877 (Trix-Col877) or His-tagged thioredoxin-Col108R (Trix-Col108R). There is a thrombin
cleavage site between the Trix and the cloned protein which is subsequently used to remove the
His-tagged thioredoxin.
4.2.2 Expression and Purification
The GenScript provided the initial expression and analysis of Col877 (result in appendix).
Small scale purification was used to analyze and optimize the expression of Col108R. The plasmid
was transformed into bacterial BL21(DE3) following BL21(DE3) transformation protocol. To test
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the expression, an isolated colony of the transformed BL21 was first inoculated in 2mL LB cell
medium containing 0.05 mg/mL ampicillin (Amp+ LB) and grew overnight in the shaker at 200
rpm at 37°C. During the second inoculation, the 200 µL cell cultures were inoculated into 10 mL
Amp+ LB media and grown at 37°C. The cells were induced by adding 1 µL of 2 M IPTG to a
final concentration of 0.2 mM IPTG when the optical density (600 nm) reached 0.4 and 0.6. After
induction, the cells were grown in the shaker at 200 rpm overnight (around 16 h) at ~20°C. The 10
mL cell cultures were spun down at 7500 rpm for 10 min at 4°C. The supernatant was discarded
and cell pellets were resuspended in 200 µL wash buffer (50 mM Tris, 300 mM NaCl) and 10 µL
of 20 mg/mL of fresh prepared lysozyme solution was added to lyse cell wall. To prevent the
proteolysis of protein, 0.4 µL of 0.1 M freshly made PMSF solution was added into cell lysate to
a final concentration of 0.2 mM. 0.2 µL of 5 kU Universal Nuclease was also added into lysed
cells. The cells were further ruptured by sonication (Vibracell, fifteen second pulses for twice,
machine output 3, duty cycle 30%). The cell lysate was spun down at 5000 rpm for 10 min at 4°C.
The supernatant was separated for purification.
HisPur Ni-NTA Spin Columns (0.2mL resin bed, ThermoFisher Scientific, Cat # 88224)
were used to purify His-tag fusion protein. The protein extracts were added into the column and
mixed on an orbital shaker for 30 minutes at 4°C. The columns were centrifuged at 700 x g for 2
minutes and the flow-through was collected in centrifuge tube as non-bonding. The resin was
washed with 400 µL wash buffer (50 mM Tris, 300 mM NaCl) wash buffer and centrifuged again,
the spin-down solution is collected and labeled “first wash”. The resin was washed with another
400 µL wash buffer additioning 10 mM imidazole, centrifuged and collected as “second wash”.
The resin was washed by 400 µL wash buffer containing 20 mM imidazole and collected as the
“third wash”. Then, the His-tagged proteins were eluted from the resin by adding 200 µL elution
buffer (50 mM Tris, 300 mM NaCl and 300 mM imidazole) and centrifuged at 700 × g for 2
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minutes. This step was repeated two more times and each fraction was collected in a separate tube
and labeled as “elution”.
The same small scale procedure was also used to analyze the expression in JM109(DE3)
cells.
Based on the small scale purification results, BL21(DE3) cells were used for further
expression and purification both Col877 and Col108R. The gene products are, respectively, Histagged thioredoxin Col877 and His-tagged thioredoxin Col108R. The fusion protein was first
purified using Ni-NTA metal affinity resin (Qiagen Cat# 30210). The thioredoxin was
subsequently removed by thrombin cleavage, and separated from protein by reverse phase HPLC.
Details of the purification procedure are described in reference (40) and methods and materials of
Chapter 2.
There are two differences between the purification of Col108 and the purification of
Col877 and Col108R. First, for Col108, the culture was grown at ~ 25°C in a shaker after induction.
For Col877 and Col108R, after the expression of protein was induced by 0.2 mM IPTG, the culture
was, then grown at ~ 20°C in a shaker cooled with ice at 200 rpm overnight (around 16 h). (The
shaker does not have cooling system. The temperature started at 15°C and maintained for a few
hours and then increased to ~20°C.) Second, for Col108, 5 mL of ~ 7 mL cleaved protein sample
was run on RP-HPLC. For Col877 and Col108R, cleaved protein sample was concentrated by
centrifugal filter tube with a molecular weight cutoff membrane of 30 kDa (Amicon Ultra
centrifugal filter, Cat #UFC903024) in a fixed angle rotor at 4000 x g for 10 minutes at 4°C to
decrease the total volume ~ 5 mL to 3 mL. 3 mL concentrated sample was run on RP-HPLC using
the same time gradient used for Col108 purfication (Figure 2-1 of Chapter 2).
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4.2.3 The structural characterization and the study of the self-assembly
The folding and thermal stability of Col877 and Col108R, and charaterization of Col877
mini-fibrils and Col108R were followed similar procedures with that of Col108 shown in methods
and materials of Chapter 2.
4.3 Results
4.3.1 The design of the peptides
The Col877 peptide was designed to have three repeating sequence units. In each sequence
unit, the col-domain in Col108 was replaced by the C877 domain which consists of the segment
of residues 877-984 of the α1 chain of type I collagen (Figure 4-1). The complete amino acid
sequence is given in Figure 4-2. The C877 domain has 108 residues, which is the same as that of
Col-domain. The region 877-984 was chosen because the segment of natural collagen contains no
Hyp and is thus, a better candidate for modeling using bacterial expression system. Additionally,
our lab previously studied the residues in the 877-939 region extensively in another recombinant
construct and have first-hand knowledge of its thermal stability and conformational properties (42).
Overall, Col877 has the same periodic sequence architecture as that of Col108 but different amino
acid composition. To relate the amino acid sequence of a collagen triple helix to its thermal
stability, we used the online tool by Dr. Persikov (http://compbio.cs.princeton.edu/csc/) (39). The
thermal stability of the 108 residue C877 domain was predicted to be around 37.4°C. This
temperature does not reflect the true thermal stability for Col877, which has three C877 domains
and other residues, but it is used as an indication of the relative stability for the peptide. For
comparison, the estimated Tm of Col-domain of Col108 is 38.2°C. We, thus, expect the Col877
should have similar stability as that of Col108.
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Figure 4-1 Schematic expression of the gene constructs of the collagen mimetic peptides. Cysteine knots
in purple, (Gly-Pro-Pro)4 in green, C877 domain in yellow, Col domain in blue, randomized Col domain in
orange, reversed Col domain in white and foldon domain in red are shown. The Col-domain, C877 domain,
revered Col-domain and randomized Col-domain all have 108 amino acid residues.

Figure 4-2 The amino acid sequence architecture of Col877. (I) The overall sequence architecture of
Coll877. The repeating units are marked with double headed arrows. The residues introduced by restriction
enzyme sites are highlighted by red box. The cysteine knots are shown in pink, (Gly-Pro-Pro)4 in green,
and foldon in red, respectively. (II) The entire amino acid sequence of Col877, with the cysteine knots, (GlyPro-Pro)4 and foldon highlighted in pink, green and red, respectively.
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Peptide Col108R was designed to have the same acid composition as that of Col108 but
without the long range periodicity of the sequences. The gene of Col108R is generated replacing
the second and the third Col-domain of the original Col108 with, respectively, a randomized
sequence of the Col-domain, and the reversed sequence of the original Col-domain (Figure 4-1);
the complete amino acid sequence is given in Figure 4-3. The randomized sequence of the Coldomain of Col108R was created by randomizing the residues at X and Y positions while keeping
the Gly at every third position. Cautions were also made to avoid region with extensive residues
of the same charges in order to avoid the charge repulsion in the structure. The randomized
sequence of Col-domain was further optimized to keep predicted thermal stability around 37.6°C
using the online tool by Persikov. The reversed sequence of original Col-domain was generated
by reversing the residues at X and Y residues within each triplet. The estimated Tm of reversed
sequence is ~36.6°C. In both peptides, the (Gly-Pro-Pro)4 sequence in each sequence unit are kept.
Thus, while Col108R has the same amino acid composition as that of Col108, the sequences in the
three sequence are different from each other. Most importantly the sequence of Col108R loses the
periodic features of Col108 (exclude the (Gly-Pro-Pro)4 inserts).
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Figure 4-3 The amino acid sequence architecture of Col108R. (I) The overall sequence architecture of
Col108R. The three units of Col108R are marked with double headed arrows. The residues introduced by
restriction enzyme sites are highlighted by red box. The cysteine knots were shown in pink, (Gly-Pro-Pro)4
in green, randomized Col domain in orange, reversed Col domain in grey and foldon in red. (II) The entire
amino acid sequence of Col108R, with the cysteine knots, (Gly-Pro-Pro)4 and foldon highlighted in pink,
green and red, respectively.

4.3.2 The sequencing of Col877 and Col108R genes.
The genes were synthesized and cloned directly into the expression plasmid using the
service by GenScript. We provided the expression plasmid, and the gene was inserted using a 5’
BamHI and a 3’ EcoRI restriction enzyme sites. After receiving the plasmid of the two peptides,
we sequenced them to confirm the sequence. Because of the large size of the genes (1170 bp) the
direct sequencing of Col877 was not complete. The sequencing confirmed 870 base pairs of the
Col877 genes shown in Appendix B. 300 base pairs in second repeating sequence unit of Col877
were not confirmed. Since GenScript provided a complete sequencing results of Col877 when the
cloned plasmid was delivered, we accepted this sequencing results as being sufficient to confirm
the accuracy of the plasmid. The complete sequence result of Col877 was shown in Appendix A.
To obtain a complete coverage of the Col108R gene by sequencing, we designed two
forward primers. One primer was designed to start ‘forward’ chain reaction from the middle of
thioredoxin so the sequencing would cover from the beginning region of Col108R to second
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sequencing unit of Col108R. The other primer was designed to start ‘forward’ chain reaction from
the second sequencing unit of Col108R. The design of this primer took into account that the
sequencing results of Col877 showing the amplification stopped at second sequencing unit. The
sequencing of Col108R using two designed inside primers resulted in complete coverage and thus,
confirmed the plasmid shown in Appendix C.

55

4.3.3 The purification of Col877
The expression of Col877 was tested by GenScript using Western blot (data in Appendix
D). We moved on to express it in BL21(DE3) host cell directly without further testing of the
expression. The fusion protein Trix-Col877 was first purified using His-tag affinity resin. The
SDS-PAGE gel was run to check if the results of elution using 300 mM imidazole (Figure 4-4).
The samples of supernatant, cell pellet, non-binding, wash1-wash3 were included to help identify
the target protein and to check the binding. The Trix-Col877 was not lost in cell pellet, non-binding
and wash1-wash3 because there were no bands of the target protein shown in these fractions. No
Trix-Col877 bands in cell pellets demonstrates that the target protein is soluble and also the cells
were completely broken by sonication to release the protein into the supernatant. No Trix-Col877
bands in non-binding solution indicates that the binding of His-tag resin and Trix-Col877 are good
enough. The particular supernatant sample was very sticky, and has low resolution; the TrixCol877 could not be clearly identified in supernatant on the gel. Trix-Col877 were present in
elution fractions shown in Lane8-Lane14 of Figure 4-4. The position of Trix-Col877 is higher than
their expected molecular weight position. On the gel, migration of the protein bands does not
correlate with their molecular weight markers because triple helical protein has a rod shape, and
move differently from globular proteins. Some non-specific binding proteins were eluted with
Trix-Col877. They were further removed by later purification procedures. The elutions that
contains fusion protein Trix-Col877 were combined, and the imidazole was removed through
dialysis.
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Figure 4-4 SDS-PAGE (12%) analysis of purification of His-tagged Col877 fusion protein expressed in
BL21(DE3) cells. On the gel, lane 2 is supernatant after sonication. Lane 3 is cell pellet after sonication.
Lane 4 is non-bonding sample. Lane 5 is first wash using solution containing 50 mM Tris and 300 mM NaCl
(pH = 7.4). Lane 6 is second wash using solution containing 50 mM Tris, 300 mM NaCl and 10mM Imidazole
(pH = 7.4). Lane 7 is third wash using solution containing 50 mM Tris, 300 mM NaCl and 20mM Imidazole
(pH = 7.4). Lane 8-14 are elution fractions. Lane 1 and 15 are low range protein makers and high range
protein markers, respectively. Fusion Col877 monomer is labeled by blue box. Fusion Col877 trimer is
identified by purple box.

Thrombin cleavage was used to remove the His-tagged thioredoxin. After thrombin
cleavage, instead of a 51 kDa fusion Col877 monomer, we would expect to see a 38.2 kDa Col877
monomer and a 14 kDa His-tagged thioredoxin. The completion of the digestion was examined
using electrophoresis (Figure 4-5). The fusion Col877 monomer band appeared to be present after
12 h cleavage (Figure 4-5, lane 2). After incubation of 24 h, the cleavage appeared to be complete;
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the fusion protein is no longer present. Interestingly, there is another band at ~ 26 kD location,
which also disappeared upon incubation with thrombin. We suspect this band represents an
incomplete chain of Col877. Col877 may be degraded during purification; or Col877 proteins may
be not fully translated during expression due to the limited number of t-RNA for Pro and/or Gly
residues. Collagen like peptides have an unusual high content of Pro and Gly. We plan to use
another proteinase inhibitor Cocktail (Clontech Cat# 635672), which is a mixture of protease
inhibitors that contain Aprotinin, Bestatin, Leupeptin, Pepstatin A and PMSF. This Cocktail is
likely more effective to protect proteins from being digested by endogenous proteases than PMSF
alone. We are also trying to use a different host cell, BL21 Codon-plus, which has multiple copies
of Pro-, Arg- and Gly-tRNA genes to improve the translation of Col877. The work is on-going.

Figure 4-5 SDS-PAGE (12%) analysis of thrombin cleavage of His-tagged Col877 fusion protein. SDSPAGE was used to follow the thrombin cleavage reaction. Lane 1 is sample before cleavage. Lane 2 is
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sample after 12 h cleavage by thrombin enzyme. Lane 3 is sample after 24 h cleavage by thrombin enzyme.
Lane 4 is high range protein marker. Blue box highlights Col877 fusion protein monomer. Red box highlights
Col877 monomer form. Yellow box labels thioredoxin.

In the final stage of purification, the Col877 was further separated from the His-tagged
thioredoxin and thrombin enzyme by HPLC. The chromatograph using absorbance spectrum at a
wavelength of 280 nm and 214 nm are shown in Figure 4-6 and Figure 4-7, respectively.

Figure 4-6 HPLC spectrum of Col877 after thrombin cleavage at 280 nm. Col877 elutes at 37% acetonitrile
(30th min). His-tagged thioredoxin elutes at 58% acetonitrile (59th min). A peak related to Col877 on the
spectrum is shown in a red box. A peak corresponding to His-tagged thioredoxin is shown in a yellow box.
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Figure 4-7 HPLC spectrum of Col877 after thrombin cleavage at 214 nm. Col877 elutes at 37% acetonitrile
(30th min). His-tagged thioredoxin elutes at 58% acetonitrile (59th min). A peak related to Col877 on the
spectrum is shown in a red box. A peak corresponding to His-tagged thioredoxin is shown in a yellow box.

The SDS-PAGE of the elutions (Figure 4-8) confirmed that Col877 eluted starting at 37%
acetonitrile (30th min - shown in red box). No bands that correlates with thrombin enzyme, or Histagged thioredoxin are present are present on the fractions of Col877 (Figure 4-8 and Figure 49A).
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The purification results of another purification of Col877 was shown in (Figure 4-9B). No
His-tagged thioredoxin is shown at 14 kDa location. Again, the sample was pure. There is no Histagged thioredoxin in the Col877 protein after HPLC separation.

Figure 4-8 SDS-PAGE (12%) analysis of fraction samples after HPLC separation. After thrombin cleavage,
Col877 was further purified by HPLC. Lane 3 -15 are fraction samples (1- 13) after collection starting at 22
min. Red box highlights Col877 monomer form.
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Figure 4-9 SDS-PAGE analysis of fraction samples after HPLC separation. (A) (continuing from Figure 410) Fractions 14 – 26 are in lane 3 – 15. Col877 monomer form is labeled by red box. (B) SDS-PAGE of
fraction samples from another purification after HPLC separation. We expected to see thioredoxin around
14.2 kDa location of protein ladder.
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4.3.4 The purification of Col108R
Small scale purification of Trix-Col108R was first conducted to improve the yield under
different expression conditions using different cell lines (JM109 and BL21(DE3) cells). The results
were analyzed using SDS-PAGE. No bands that correlate with Trix-Col108R were present in
“non-banding”, “wash1” and “wash2” (Figure 4-10A). This result demonstrates that the binding
of His-tagged resin and Trix-Col108R were good and no Trix-Col108R were lost in non-binding
and wash for resin. The eluted fusion Col108R proteins were shown in lane 6 -13 (Figure 4-10B).
The band of fusion protein under the condition of OD = 0.6 in BL21(DE3) cells was thicker than
others. This result indicates that Col108R has better expression yield with induction at OD 0.6 in
BL21(DE3) cells. We therefore, chose to use this condition for large scale purification.
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Figure 4-10 SDS-PAGE (12%) analysis of small scale purification of Col108R in different conditions. (A)
Lane 2 and 3 are low range and high range protein marker, respectively. Lane 4, 8 and 12 are respectively
non-bonding, first wash and second wash samples expressed in JM109 and induced when OD = 0.4. Lane
5, 9 and 1 are non-bonding, first wash and second wash samples expressed in JM109 and induced at OD
= 0.6. Lane 6, 10 and 14 are non-bonding, first wash and second wash samples expressed in BL21(DE3)
and induced at OD = 0.4. Lane 7, 11 and 15 are non-bonding, first wash and second wash samples
expressed in BL21(DE3) and induced at OD = 0.6. (B) Lane 2, 6 and 10 are third wash, first elution, and
second elution samples expressed in JM109 and induced when OD = 0.4. Lane 3, 7 and 11 are third wash,
first elution, and second elution samples expressed in JM109 and induced at OD = 0.6. Lane 4, 8 and 12
are third wash, first elution, and second elution samples expressed in BL21(DE3) and induced at OD = 0.4.
Lane 5, 9 and 13 are third wash, first elution, and second elution samples expressed in BL21(DE3) and
induced at OD = 0.6. Lane 1 is low range protein marker.

The purification results of Col108r using 300 mM imidazole are shown in Figure 4-11.
Trix-Col108R were present in elution using 300 mM imidazole (lane1-lane8 of Figure 4-11). TrixCol108R moved similarly on the gel as Trix-Col877 and Trix-Col108. The position of Trix64

Col108R band on the gel is higher than their expected molecular weight position, which is common
for rod-like triple-helix proteins.

Figure 4-11 SDS-PAGE (15%) analysis of purification of His-tagged Col108R expressed in BL21(DE3) cells.
SDS-PAGE was run to check the purification results. Lane 1-8 are elution samples. Lane 9 are low range
protein makers. Trix-Col108R monomer is labeled by blue box. Trix-Col108R trimer is highlighted by purple
box.

The completion of the cleavage of Trix-Col108R was examined using electrophoresis
(Figure 4-12). After 24 h cleavage, the band of 52 kDa fusion protein Col108R monomer
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disappeared and the band of 38.5 kDa Col108R monomer was present. The gel was run out of the
bottom line so we cannot see the band of Trix at 14.2 kDa location in lane 3 of Figure 4-12. Two
bands around 40 kDa position of protein ladder disappeared after thrombin cleavage. This may be
caused by imcomplete translation during expression or degradation by proteinase. This situation
of Col108R is similar as Col877. The solution has been mentioned in the result section of Col877
purification. After thrombin cleavage, an unknown band was shown around 72 kDa location of
protein ladder in lane 3 of Figure 4-12. We cannot identify what this band is.

Figure 4-12 SDS-PAGE (15%) analysis of thrombin cleavage of His-tagged Col108R protein. SDS-PAGE
was used to follow the thrombin cleavage reaction. Sample before dialysis is in lane 2. Sample after 24 h
cleavage by thrombin enzyme is in lane 3. Lane 1 and 4 are low range and high range protein markers,
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respectively. Blue box highlights Col108R fusion protein monomer. Red box highlights Col108R monomer
form.

The elution gradient for Col108R purification using HPLC is the same with that of Col877.
The chromatograph using spectrum at a wavelength of 280 nm and 214 nm are shown in Figure 413 and Figure 4-14.

Figure 4-13 HPLC spectrum of Col108R after thrombin cleavage at 280 nm. Col108R elutes at 37%
acetonitrile (30th min). His-tagged thioredoxin elutes at 57% acetonitrile (58th min). A peak corresponding
to Col108R on the spectrum is shown in a red box. A peak corresponding to His-tagged thioredoxin is
shown in a yellow box.
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Figure 4-14 HPLC spectrum of Col108R after thrombin cleavage at 214 nm. Col108R elutes at 37%
acetonitrile (30th min). His-tagged thioredoxin elutes at 57% acetonitrile (58th min). A peak corresponding
to Col108R on the spectrum is shown in a red box. A peak corresponding to His-tagged thioredoxin is
shown in a yellow box.

The SDS-PAGE of the elution (Figure 4-15 and Figure 4-16) confirmed that Col108R
peptide eluted started at ~ 37% acetonitrile (30th min - shown in red box). The His-tagged
thioredoxin peak in Col108R absorbance spectrum is smaller than that in Col877 absorbance
spectrum because Col108R sample was concentrated by centrifugal filter tube with a molecular
weight cutoff membrane of 30 kDa. The molecular weight of His-tagged thioredoxin is ~ 14 kDa.
Most of His-tagged thioredoxin is separated from Col108R through centrifugal filter tube. No
bands that correlates with thrombin enzyme or His-tagged thioredoxin were present on the
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fractions of Col108R after HPLC separation (Figure 4-16). There are no other contaminants on the
gel. This result demonstrates that the Col108R sample was pure.

Figure 4-15 SDS-PAGE (15%) analysis of fraction samples after HPLC separation. Lane 1-9, 11 and 12
are fraction samples 1-8 and 15-17 after collection starting at 18 min. Lane 10 is low range protein marker.
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Figure 4-16 (continuing from Figure 4-17) Fractions 18 – 24 are in lane 5 – 11. Col108R monomer form is
labeled by red box. Col108R trimer and dimer are highlighted by green box. Thioredoxin is highlighted by
yellow box. Lane 2 and lane 3 are samples taken from before thrombin cleavage and after cleavage,
respectively. Trix-Col108R monomer and Col108R monomer are shown in blue and red, respectively. Lane
1 and 4 are low range and high range protein markers.

4.3.5 The folding and the thermal stability of Col877 and Col108R
CD spectra of Col877 and Col108R similar with CD spectra of Col108 demonstrated that
Col877 and Col108R formed triple-helical structure (Figure 4-17). The thermal stability was
monitored by the change of CD signal at 225 nm with the temperature from 4°C to 55°C. The
temperature of the thermal transition (Tm) of Col877 is about 39°C (Figure 4-18). The Tm of
Col108R is about 38°C (Figure 4-18). Compared to Tm of Col108, which has a Tm of 41°C, thermal
stability of Col877 and Col108R is slightly lower than that of Col108. While, Col877 triple helices
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are stable at incubation temperature of fibril formation (37°C or 26°C), Col108R triple helices may
not be stable at incubation temperature of 37°C, and for this reason, the fibril formation was done
at 26°C.
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Figure 4-17 Circular dichroism spectra of Col877 and Col108R. CD spectra of Col877 (red filled squares)
and Col108R (blue filled triangles) were recorded in 5 mM acetic acid at 4°C and final concentration of
1mg/mL. CD spectrum of 0.4 mg/mL Col108 (black open circles) in 5 mM acetic acid 4°C is as a comparison.
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Figure 4-18 Temperature melting curve of Col877 and Col108R from 4°C to 55°C. The thermal unfolding
of 1mg/mL Col877 (red filled squares) and 1mg/mL Col108R (blue filled triangles) triple helix was monitored
by at 225 nm, and normalized to fraction of folded. Temperature melting curve of 1 mg/mL Col108 (black
open circles) is as a comparison.

4.3.5 Electron microscopy study of the self-assembly of Col877 and Col108R
4.3.5.1 Self-association of Col877
The fibrillogenesis was carried out in the same way as that of Col108. I have examined ~36
grids made from different solutions and from two different purifications of Col877. All staining
solutions were fresh made within one week. I examined 20 grids made from protein samples of
one purification. I have observed the same mini-fibrils from most of the 20 grids observed. It is
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not easy to find the mini-fibrils on the grids due to the small quantity of mini-fibrils. If the
concentration of protein samples is increased, it might solve this problem. For those I failed to see
mini-fibrils I found large aggregates, but the banding pattern is not clear. This could be caused by
ineffective staining. All results are shown in Figure 4-19(A-D). In Figure 4-19(A-B), there are
some mini-fibrils with obscure banding pattern. The mini-fibrils are ~ 650 nm to 1µm in length
and 40 nm to 95 nm in diameter. The exact length of mini- fibrils is difficult to determine because
the ends of individual long mini-fibrils overlap together. The good TEM micrographs of minifibrils revealing clear banding pattern are in Figure 4-19(C-D). Overall, the Col877 mini-fibrils
have the same banding pattern as that of Col108 (Figure 2-7) when examined using electron
microscopy with negative staining under different magnification. The d-periodicity of banding
pattern is ~ 35 nm estimated from the negatively stained fibrils, consisting of a dark band of ~ 25
nm (0.7d) and a light band of ~ 10 nm (0.3d).
I examined ~ 16 grids made from Col877 sample of another purification at two different
incubation temperatures. The mini-fibrils are still found in most of these grids in both incubation
temperature. For the incubation temperature of 37°C, the TEM images showing clear banding
pattern are in Figure 4-19(E-H). The Col877 mini-fibrils have similar features with that of sample
from previous purification. The mini-fibrils are about 700 nm – 1 um in length, with the diameters
of the mini-fibrils varying between ~ 40 to ~ 90 nm. This result indicates that self-assembly of
Col877 into mini-fibrils is reproducible. For the incubation temperature of 26°C, the mini-fibrils
with the same banding pattern were found in TEM micrographs (Figure 4-20). The banding pattern
on a few TEM images is not clear. This might be caused by ineffective staining. The mini-fibrils
after incubation at 26°C are ~600 nm to 1µm in length and 35 nm to 95 nm in diameter.
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Figure 4-19 The TEM images of Col877 mini-fibrils incubated at 37°C. (A-H) the negatively stained Col877
mini-fibrils after 24 h incubation at 37°C. A-D made from Col877 sample of one purification. E-H made from
Col877 sample of the other purification. B, C, D, F and H are at magnification 10000 X. A, E and G are at
magnification 6000 X.

Figure 4-20 The TEM images of Col877 mini-fibrils incubated at 26°C. (A-B) the negatively stained Col877
mini-fibrils after 24 h incubation at 26°C. A is at magnification 10000 X. B is at magnification 5000X.

Col877 in 5 mM acetic acid at 4°C was conducted as a control. No mini-fibril-like structure
is found under the examination of TEM (Figure 4-21). An individual Col877 triple helix is
approximately 120 nm long and 1.5 nm in diameter. Some thread looking structures are observed
on the TEM images of Col877 in 5 mM acetic acid. These structures appear to be Col877
monomers based on their size. Also, there are a few aggregates shown on TEM micrographs. These
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aggregates are a bit larger than Col877 monomer and have very different appearances from Col877
mini-fibrils.

Figure 4-21 The TEM images of Col877 in 5 mM acetic acid. (A-B) Col877 in 5 mM acetic acid at 4°C. A
and B are at magnification 20000 X.
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4.3.5.2 Self-association of Col108R
Col108R in TES buffer were carried out at different incubation time of 6 h, 12 h and 24 h
at 37°C, and also at incubation time of 24 h at 26°C since its melting temperature is ~ 38°C, lower
than those of Col108 and Col877. I have examined ~30 grids made from different samples prepared
using of the peptide from two purifications, with incubation times 6 h, 12 h or 24 h at 37°C. No
fibril-like assembles were observed on any of all grids (Figure 4-22). Under TEM, some aggregates
were observed with 24h incubation time (Figure 4-22(A-B)). The diameter of the aggregates is ~
10 nm, which is smaller than that of Col877 mini-fibrils. There is no banding pattern in the
aggregates. Some aggregates that have non-regular morphology exist on the TEM images with
another incubation time of 6 h and 12 h (Figure 4-22(C-F)). None of these aggregates looks like
periodic mini-fibrils.
I also prepared the samples for self-association incubated at 26°C. I examined ~ 10 grids
from two different purification samples. Under TEM, still no mini-fibrils-like aggregates were
found on all grids (Figure 4-23). Peptide Col108 was shown to form d-periodicity mini-fibrils at
both 37°C and 26°C incubation temperatures (40). All Col108R aggregates that found under TEM
after incubation at 26°C are obviously different from the mini-fibrils of Col108 or Col877. This
result support our hypothesis that the repeating sequence units are important for fibril formation.
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Figure 4-22 The TEM images of Col108R at different incubation times. (A-B) No fibrils-like aggregates of
Col108R after 24 h incubation at 37 °C. (C-D) Col108 aggregates after 12 h incubation at 37 °C. (E-F)
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Col108 aggregates after 6 h incubation at 37 °C. A, C and E are at magnification 6000 X. B and D are at
magnification 10000 X. F is at magnification 12000 X.

Figure 4-23 The TEM images of Col108R at the other incubation temperature. (A-B) Col108R after 24 h
incubation at 26 °C. A is at magnification 6000 X. B is at magnification 10000 X.

4.4 Summary
Two new collagen mimetic peptides (Col877 and Col108R) were designed and built to test
if sequence periodicity is crucial factor for the self-assembled mini-fibrils of Col108. Col877 has
built-in repeating sequence units in its primary structure. Col108R does not have long range
sequence periodicity in its sequence. The results indicate that Col877 triple helix can self-assemble
into mini-fibrils with the same d-periodicity of those of Col108 mini-fibrils under appropriate
conditions. Col108R triple helix, on the other hand, form stable triple helix but could not selfassemble to fibrils-like assembles, even after reducing the incubation temperature to 26°C. These
data support our hypothesis that the periodicity in the sequence architecture in Col108 are
important for mini-fibril formation.
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The d-period of the Col877 mini-fibrils indicate that the self-assembly is driven by the
repeating sequence architecture, and not specific residues in the repeating sequence units. Col877
which has the same repeating sequence architecture as that of Col108 but having a completely
different sequence also form mini-fibrils with the identical periodicity as that of Col108 minifibrils. The ~35nm d-period corresponds to a 123 residue pseudo-repeating sequence unit of
Col877, and the overlap region (0.3d) of mini-fibrils is from C terminal foldon domain, (Gly-ProPro)4 nucleation domain and Cysteine knots. This one-unit staggered assembly is most stable
arrangement because hydrophobic residues interact with hydrophobic residues of triple helices and
charged residues interact with charges residues. In the contrary, Col108R triple helices that lose
long range sequence periodicity and did not show any sign of self-assembled mini-fibrils with dperiodicity. This also supports our proposed model.
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Chapter 5. Discussion
We created four collagen mimetic peptides 2U108, 1U108, Col877 and Col108R to study
the determining factors for self-assembly of collagen mimetic mini-fibrils. 2U108 has two
repeating sequence units and 1U108 has only one sequence unit. Col877 has three repeating
sequence units but different amino acids composition with Col108. Col108R which has the same
amino acid composition of that of Col108 lacks repeating sequence architecture. Both 2U108 and
Col877 triple helices self-assembles into mini-fibrils with identical d periodicity, which agrees in
size of their repeating sequence unit. But no fibrils-like assembles are found in Col108R or 1U108
since both peptides lack the long-range sequence periodicity. The one-unit staggering model
appears to apply for both Col877 and 2U108, which produces in-register alignment of interacting
residues of neighboring triple helices as shown in Figure 5-1A and in reference (46), respectively.
The white parts represent some large hydrophobic residues (valine, methionine, leucine, isoleucine
and phenylalanine); blue and red lines represent the positive and negative charged residues. In oneunit staggered arrangement, these residues form the triple helices will be placed in the close
vicinity of comparable residues from the adjacent helices to promote stabilizing interaction. The
interactions of hydrophobic residues, and charged residues between neighboring triple helices are
maximized in this arrangement. These interactions stabilize the staggered structure. On the other
hand, the one-unit staggered pattern of Col108R fibril model is shown in Figure 5-1B. The inregister alignments of the charged and hydrophobic residues of the neighboring triple helices are
lost. Therefore, the one-unit staggered arrangement of Col108R does not represent an optimally
stabilized conformation and does not lead to the formation of the one-unit staggered fibrils.
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Figure 5-1 Predicted assembled triple helices models. (A) predicted Col877 fibril model showing charge
distribution. (B) predicted Col108r fibril model showing charge distribution. The three sequence units of the
peptide are separated by black vertical bar; Blue vertical bars show positive charge residues; Red vertical
bars show negative charge residues; The oval represents foldon domain.

Overall, three collagen mimetic peptides Col108, 2U108 and Col877 self-associate into
identical d-period mini-fibrils. These peptides have similarities in their primary structures. The
prominent feature is that all of them have at least two repeating sequence units. 1U108 and
Col108R assemble into non-specific aggregates other than d-periodic mini-fibrils because these
two peptides lack tandem repeats of sequence units. Therefore, lacking sequence periodicity in the
primary sequence will induce non-specific aggregates.
The foldon domain at C terminal end contributes to stabilizing interactions of 2U108,
Col877 and Col108 mini-fibrils. In one-unit staggered arrangement, the residues on the surface of
foldon domain may interact with neighboring helices and contribute to the stability of the minifibril assembly. But the foldon domain is not a determining factor for self-assembly of mini-fibrils.
1U108 and Col108R that have foldon domain at C terminus only formed non-specific aggregates.
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In the contrary, because the size of the foldon domain its presence may limited the growth of the
mini-fibrils. Foldon has a beta hairpin conformation. Although smooth mini-fibrils formed
indicates that foldon domain can be accommodated in the packing of triple helices, foldon domain
has a diameter of 2.5 nm (50), which is a bit larger than that of a triple helix (1.5 nm). The foldon
domains inside the mini-fibrils may induce steric tension that impedes the growth of fibril
formation.
Another critical factor to have for the formation of the alternating gap-and-overlap
structure of the mini-fibrils is the inclusion of the overhang region of the peptides, which consists
of the foldon, the C-terminal (Gly-Pro-Pro)4, and the Cys-knot sequences at the N- and the Ctermini. The 0.3d overhang contributes to the overlap region of the d-period. Yoshizumi et al
reported that a collagen-like construct CL-CL which has two collagenous repeating sequence units
self-associate into fibrillar structures (32,33). But this fibrillar structures do not have any
periodicity. This may be caused by construct CL-CL lacking an overhang unit based on our
analyses of our collagen mimetic peptides. In our collagen mimetic peptides, the 0.3d overhang
unit consists of a N-terminal cysteine knot, a C-terminal nucleation domain, a C-terminal cysteine
knot and a C-terminal foldon domain. If they add an overhang unit into CL-CL, CL-CL molecules
may self-associate into fibrils with periodicity.
For the further study, it will be interesting to replace foldon with another trimerization
domain. Globular protein V domain is another trimerization domain of bacterial collagen and is at
N terminal end (51), which can be a good candidate. This domain can subsequently be removed
by protease digestion. Finding the replacement of foldon domain will contribute to generate stable
and may be longer collagen mimetic fibrils. Based on our design rule, we can design other collagen
mimetic peptides with two repeating sequence units, an overhang unit consisting of partial
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collagenous domain and V domain at N terminal end to associate into periodic fibrils. The
development of collagen mimetic peptides will lead to a better understanding of the fibrillogenesis
of collagen, and the development of new biomaterials for the application in medicine,
pharmaceuticals and cosmetics.
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APPENDIX
A. The result of Col877 DNA sequencing by GenScript
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B. The result of Col877 DNA sequencing by GENEWIZ
Thursday, December 03, 2015 3:58 AM
Project: 701658.sqd Contig 1
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GTTCTGGTATGAGCGATAAAATTATTCACCTGACTGACGACAGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
Col877
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Col877
Col877
Col877
Col877
Col877

4-T7.ab1(93>608)
5-T7.ab1(92>654)
7-T7.ab1(89>669)
2-T7.ab1(91>719)
1-T7.ab1(90>708)
6-T7.ab1(122>673)
3-T7.ab1(125>694)

GTTCTGGTATGAGCGATAAAATTATTCACCTGACTGACGACAGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
TCTGGTATGAGCGATAAAATTATTCACCTGACTGACNACAGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
TCTGGTATGAGCGATAAAATTATTCACCTGACTGACGACAGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
TCTGGTATGAGCGATAAAATTATTCACCTGACTGANNANNGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
TCTGGTATGAGCGATAAAATTATTCACCTGACTGACGACAGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
AGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
AGTTTTGACACGGATGTACTCAAAGCGGACGGGGCGATC
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CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
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CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
CTCGTCGATTTCTGGGCAGAGTGGTGCGGTCCGTGCAAAATGATCGCCCCGATTCTGGATGAAATCGCTGACGAATATCA
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Col877
Col877
Col877
Col877
Col877
Col877

4-T7.ab1(93>608)
5-T7.ab1(92>654)
7-T7.ab1(89>669)
2-T7.ab1(91>719)
1-T7.ab1(90>708)
6-T7.ab1(122>673)

GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGG
GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGGGTCCGCAGGGCCCGCGTGGTGACAAGGGCGAGACCGGTGAACAA
GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGGGTCCGCANGGCCCGCGTGGTGACAAGGGCGAGACCGGTGAACAA
GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGGGTCCGCAGGGCCCGCGTGGTGACAAGGGCGAGACCGGTGAACAA
GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGGGTCCGCAGGGCCCGCGTGGTGACAAGGGCGAGACCGGTGAACAA
GCCCGGTTGGTCCGGTTGGTGCGCGTGGCCCGGCGGGTCCGCAGGGCCCGCGTGGTGACAAGGGCGAGACCGGTGAACAA
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The results of seven Col877 plasmids using forward primer of T7 promotor and reverse primer of T7
terminator are showed in green arrow and red arrow, respectively. The region that was not covered is
highlighted using a red box. The bases are not identified are labeled as N. Col877.seq(1>1263) is the
Col877 DNA sequence provided by GenScript.
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C. The result of Col108R DNA sequencing analyzed using Bioedit software

91

92

93

94

The result of one Col108R plasmid using two designed forward primers are showed as
108R1_vseqF and 108R1_1seq1, respectively. The bases are not identified are labeled as N. 108R
is the Col108R DNA sequence provided by GenScript.
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D. Protein Expression Evaluation of Col877 in E.coli done by GenScript
Summary
E. coli BL21 (DE3) was transformed with the recombinant plasmid. A single colony was
inoculated into LB medium containing ampicilin; cultures were incubated in 37 °C at 200
rpm. Once cell density reached to OD=0.6-0.8 at 600 nm, IPTG was introduced for induction.
Western blot was used to monitor the expression (Figure D-1).
Results

Figure D-1 Col877 expression analyzed by Western blot (using anti-His antibody, GenScript Cat.No.
A00186). Lane 1: Cell lysate with induction for 16 h at 15°C. Lane 2: Cell lysate with induction for 4 h at
37°C. Lane 3: Supernatant of cell lysate with induction for 16 h at 15°C. Lane 4: Pellet of cell lysate with
induction for 16 h at 15°C. Lane 5: Supernatant of cell lysate with induction for 4 h at 37°C. Lane 6: Pellet
of cell lysate with induction for 4 h at 37°C

Conclusion
The Western blot result showed that Col877 was expressed with degradation in E.coli.
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